Table 2. Summary of baseline demographic variables and relevant comorbidities and medications for all patients according to coated-platelet tertiles.
| Baseline valuesa |
Coated-platelet level (%) |
P value | ||
|---|---|---|---|---|
| Lowest tertile (n=60) | Middle tertile (n=60) | Upper tertile (n=60) | ||
| Age (years) | 65.8 (12.0) | 68.3 (11.1) | 63.2 (11.1) | 0.053 |
| NIHSS | 14.4 (9.3) | 11.0 (7.0) | 12.6 (8.6) | 0.086 |
| Male sex | 46 (77%) | 40 (67%) | 48 (80%) | 0.22 |
| Race/ethnicity (white versus nonwhite) | 0.18 | |||
| White | 37 (62%) | 45 (75%) | 45 (75%) | |
| African American | 22 (36%) | 14 (23%) | 14 (23%) | |
| Hispanic | 0 | 0 | 1 (2%) | |
| Native American | 1 (2%) | 0 | 0 | |
| Other | 0 | 1 (2%) | 0 | |
| Current smoker | 31 (52%) | 23 (38%) | 31 (52%) | 0.24 |
| Statin use | 25 (42%) | 22 (37%) | 23 (38%) | 0.85 |
| Antiplatelet use | 39 (65%) | 33 (55%) | 31 (52%) | 0.31 |
| SSRI use | 3 (5%) | 5 (8%) | 6 (10%) | 0.69 |
| Prior TIA/stroke | 8 (13%) | 12 (20%) | 7 (12%) | 0.40 |
| Prior CAD | 21 (35%) | 16 (27%) | 14 (23%) | 0.34 |
| Diabetes | 23 (38%) | 16 (27%) | 20 (33%) | 0.39 |
| End stage renal disease | 3 (5%) | 2 (3%) | 2 (3%) | 0.80 |
| Cardioembolism | 18 (30%) | 18 (30%) | 14 (23%) | 0.64 |
| Atrial fibrillation | 11 (18%) | 10 (17%) | 9 (15%) | 0.89 |
| Hypertension | 39 (65%) | 48 (80%) | 48 (80%) | 0.091 |
| Hypercholesterolemia | 29 (48%) | 28 (47%) | 28 (47%) | 0.98 |
| Large artery disease | 16 (27%) | 23 (38%) | 16 (27%) | 0.28 |
CAD, coronary artery disease; NIHSS, National Institutes of Health Stroke Scale; SSRI, selective serotonin reuptake inhibitors; TIA, transient ischemic attack.
a
Data are summarized using the mean and s.d. or count (%).